Details

NameSymbolSector
DR. REDDY'S LABORATORIES LIMITEDDRREDDYPharmaceuticals
Open
1255.1
High
1266
Low
1250.2
Close
1260.4
Volume
1603933
Exchange
nse
Time
14/08

Outlook

Score:

4

Rating:

FAIR

Candlestick Pattern

CandlepatternofDr.Reddy'sLaboratoriesis
Short Line
EstimatedStoplossofDr.Reddy'sLaboratoriesis
1250.2
Dr.Reddy'sLaboratorieshasa
Bullishℹ
pattern.
Formationof
Short Line
candlepatternindicatesthetrenddirectionofDr.Reddy'sLaboratoriesis
Unpredictableℹ
.

Trend

Dr.Reddy'sLaboratoriesisin
Sideways trendℹ
.
PriceofDr.Reddy'sLaboratoriesis
Downℹ
by

0.44

%.
Target
Buy@

1191.02

Sell@

1360.6

Volume

ThetradevolumesofDr.Reddy'sLaboratorieshavebeen
Underperformingℹ
ThevolumetrendforDr.Reddy'sLaboratoriesis
Bearishℹ
,buttheparticipantsare
Weak Sellersℹ
ThetradevolumeofDr.Reddy'sLaboratoriesis

Up

by

3.7

%

Valuation

ThecurrentmarketpriceofDr.Reddy'sLaboratoriesis
Undervaluedℹ

Financials

Balance
ThebalancesheetofDr.Reddy'sLaboratoriesis:

Balanced

Cashflow
Dr.Reddy'sLaboratorieshas
Excellentℹ
cashflowbecausethereis

Surplus

of

₹ 748cr

.Itis
Upℹ
by

466.67

%.
37.55% i.e. ₹ 4642cr earned in operatingℹ
46.97% i.e. ₹ 5807cr spent in investingℹ
15.3% i.e. ₹ 1891cr earned in financingℹ
0.18% i.e. ₹ 22cr earned in otherℹ
Dr.Reddy'sLaboratorieshas
Maintainedℹ
cashflowbecausethereis

Surplus

of

₹ 132cr

.Itis
Upℹ
by

114.55

%.
50.75% i.e. ₹ 4543cr earned in operatingℹ
45% i.e. ₹ 4028cr spent in investingℹ
4.2% i.e. ₹ 376cr spent in financingℹ
0.06% i.e. ₹ 5cr spent in otherℹ
Income
TheincomeofDr.Reddy'sLaboratoriesis

₹ 8862cr

and

Profit

is:

₹ 1409cr

Dr.Reddy'sLaboratoriesProfitisdownby:

10.88

%andIncomeisDownby:

2.08

%
TheincomeofDr.Reddy'sLaboratoriesis

₹ 9050cr

and

Profit

is:

₹ 1581cr

Dr.Reddy'sLaboratoriesProfitisupby:

12.93

%andIncomeisUpby:

6.08

%
TheincomeofDr.Reddy'sLaboratoriesis

₹ 8531cr

and

Profit

is:

₹ 1400cr

Dr.Reddy'sLaboratoriesProfitisupby:

4.87

%andIncomeisUpby:

2.23

%
By using this site you agree to the use of cookies to deliver a better site experience.